111 related articles for article (PubMed ID: 11438169)
21. Morphine-induced thymic hypoplasia is glucocorticoid-dependent.
Sei Y; Yoshimoto K; McIntyre T; Skolnick P; Arora PK
J Immunol; 1991 Jan; 146(1):194-8. PubMed ID: 1824589
[TBL] [Abstract][Full Text] [Related]
22. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
Ignar DM; Kuhn CM
J Pharmacol Exp Ther; 1990 Dec; 255(3):1287-95. PubMed ID: 2175800
[TBL] [Abstract][Full Text] [Related]
23. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
24. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells.
Crain SM; Shen KF
Brain Res; 1996 Nov; 741(1-2):275-83. PubMed ID: 9001733
[TBL] [Abstract][Full Text] [Related]
25. Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages.
Tomassini N; Renaud FL; Roy S; Loh HH
J Neuroimmunol; 2003 Mar; 136(1-2):9-16. PubMed ID: 12620638
[TBL] [Abstract][Full Text] [Related]
26. No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters.
D'Elia M; Patenaude J; Hamelin C; Garrel DR; Bernier J
Clin Immunol; 2003 Nov; 109(2):179-87. PubMed ID: 14597216
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of morphine, DPDPE, and U-50488 on apomorphine-induced climbing behavior in mu-opioid receptor knockout mice.
Jang CG; Lee SY; Park Y; Ma T; Loh HH; Ho IK
Brain Res Mol Brain Res; 2001 Oct; 94(1-2):197-9. PubMed ID: 11597780
[TBL] [Abstract][Full Text] [Related]
28. Involvement of mu-opioid receptors in potentiation of apomorphine-induced climbing behavior by morphine: studies using mu-opioid receptor gene knockout mice.
Jang C; Park Y; Tanaka S; Ma T; Loh HH; Ho IK
Brain Res Mol Brain Res; 2000 May; 78(1-2):204-6. PubMed ID: 10891603
[TBL] [Abstract][Full Text] [Related]
29. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
[TBL] [Abstract][Full Text] [Related]
30. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.
Gustafsson H; Afrah AW; Stiller CO
J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973
[TBL] [Abstract][Full Text] [Related]
31. Behavioral sensitization to intermittent morphine in mice is accompanied by reduced adrenocorticotropine but not corticosterone responses.
Jezova D; Mlynarik M; Zelena D; Makara GB
Brain Res; 2004 Sep; 1021(1):63-8. PubMed ID: 15328032
[TBL] [Abstract][Full Text] [Related]
32. Pleiotropic effects of morphine-6beta-glucuronide.
Lötsch J
Anesthesiology; 2009 Jun; 110(6):1209-10. PubMed ID: 19417609
[No Abstract] [Full Text] [Related]
33. Glucocorticoid hormone regulates the circadian coordination of micro-opioid receptor expression in mouse brainstem.
Yoshida M; Koyanagi S; Matsuo A; Fujioka T; To H; Higuchi S; Ohdo S
J Pharmacol Exp Ther; 2005 Dec; 315(3):1119-24. PubMed ID: 16109741
[TBL] [Abstract][Full Text] [Related]
34. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
Eisenberg RM
J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
[TBL] [Abstract][Full Text] [Related]
35. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
36. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
[TBL] [Abstract][Full Text] [Related]
37. Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.
Kibaly C; Lin HY; Loh HH; Law PY
Pharmacol Res; 2017 May; 119():153-168. PubMed ID: 28179123
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors.
Reche I; Fuentes JA; Ruiz-Gayo M
Eur J Pharmacol; 1996 Dec; 318(1):11-6. PubMed ID: 9007506
[TBL] [Abstract][Full Text] [Related]
39. Preprodynorphin mediates locomotion and D2 dopamine and mu-opioid receptor changes induced by chronic 'binge' cocaine administration.
Bailey A; Yoo JH; Racz I; Zimmer A; Kitchen I
J Neurochem; 2007 Sep; 102(6):1817-1830. PubMed ID: 17532787
[TBL] [Abstract][Full Text] [Related]
40. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.
Xiong W; Yu LC
Neurosci Lett; 2006 May; 399(1-2):167-70. PubMed ID: 16490317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
